Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
List of most commonly encountered drugs currently controlled under the Misuse of Drugs legislation
It produces more modest results than semaglutide or tirzepatide, typically around 8 percent body weight loss, but it was the first GLP-1 to receive FDA approval specifically for weight management and remains a viable option for patients who prefer a shorter-acting medication or who experience intolerable side effects on the more potent formulations
It is suitable for advanced experimental work in pigmentation, metabolic regulation, and neuroendocrine pathways
PMC 2756298
US$ 24.45
US$ 29.43
US$ 27.13
